Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 1

THC and CBD: A Controlled Human Study Probing a Harm Reduction Strategy

University of California, Los Angeles · NCT06859710

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 21–55 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Phase 1
Target enrollment
30
US sites recruiting
1
Study start
November 5, 2025
Record last updated
December 17, 2025

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The purpose of this research is to assess the impact of CBD on the effects of THC.

Being studied: Placebo; THC; CBD 20 mg; CBD 40 mg; CBD 80 mg

Conditions: Abuse, Drug; Pain

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Male or non-pregnant and non-lactating females aged 21-55 years
  • Report cannabis use 1-7 days per week over the month prior to screening
  • Not currently seeking treatment for their cannabis use
  • History of inhaled cannabis use
  • Have a Body Mass Index from 18.5 - 34 kg/m2
  • Able to perform all study procedures
  • Must be using a contraceptive (hormonal or barrier methods)

Exclusion Criteria

  • Meeting DSM-V criteria for severe Cannabis Use disorder (CUD) or any substance use disorder other than nicotine, caffeine, mild or moderate CUD
  • Evidence of severe psychiatric illness (e.g. mood or anxiety disorder with functional impairment or suicide risk, schizophrenia) judged by the study physician (and PI) to put the participant at greater risk of experiencing adverse events due to completion of study procedures, interfere with their ability to participate in the study, or their capacity to provide informed consent.
  • Report using other illicit drugs in the prior 4 weeks
  • Current pain
  • Pregnancy
  • Currently enrolled in another research protocol
  • Not using a contraceptive method (hormonal or barrier methods)
  • Insensitivity to the cold water stimulus of the Cold Pressor Test
  • Any disorders that might make cannabis administration hazardous as determined by evaluation physician after review of all medical assessments along with medical history.
  • Not able to speak and read English

Recruiting US locations

  • UCLA Center for Cannabis and Cannabinoids

    Los Angeles, CA 90095

    Site contact: Ziva D Cooper, PhD · (310) 794 -1497 · cannabislab@mednet.ucla.edu

Study contacts (from the official record)

  • Ziva Cooper, PhD · 310-206-9942 · zcooper@mednet.ucla.edu
  • Vincent Acebo · 310-983-3417 · vacebo@mednet.ucla.edu
THC and CBD: A Controlled Human Study Probing a Harm Reduction… (NCT06859710) | Bored Studies